Telesis Bio Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Telesis Bio Inc inventory turnover ratio, the Telesis Bio Inc 's ability to sell and replace its inventory in the third quarter 2024, sequentially increased to 2.98 in the third quarter 2024, yet the ratio remained below the average, as TBIO's market remain challenging.Average inventory processing period, for the Telesis Bio Inc in Sep 30 2024 quarter, has decreased to 122 days, compare to 135 days, in the Jun 30 2024 quarter.

Within Healthcare sector 137 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the Third Quarter 2024 compared to previous quarter at no. 1218.

TBIO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Telesis Bio Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TBIO Inventory Turnover Ratio	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter
Y / Y Inventory Growth	-74.26 %	-64.85 %	59.94 %	82.95 %	-
Y / Y Cost of Sales Growth	-72.15 %	0 %	-50 %	32.32 %	-
Inventory Turnover Ratio (TTM)	2.98	2.7	2.27	2.77	2.86
TBIO's Total Ranking	# 1218	# 1218	# 1222	# 1053	# 891
Average inventory processing period	123	135	160	132	128
Seq. Inventory Growth	-19.01 %	-63.01 %	-8.84 %	-5.74 %	10.59 %
Seq. Cost of Sales Growth	-72.15 %	100 %	-75 %	100 %	0 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 5
Healthcare Sector	# 138
Overall Market	# 1218

Inventory Turnover Ratio Statistics
High	Average	Low
10.44	3.12	1.34
(Sep 30 2018)		(Jun 30 2019)

TBIO Company Profile >> Back to TBIO Efficiency Comparisons >> Compare TBIO Inventory Turnover Ratio to its Competitors

Financial Statements
Telesis Bio Inc 's Inventories	$ 1 Millions	Visit TBIO's Balance sheet
Telesis Bio Inc 's Cost of Revenues TTM	$ 8 Millions	Visit TBIO's Income Statement
What are TBIO's Sales?		Visit TBIO's Sales by Segment

Other Inventory Turnover Ratios
Telesis Bio Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
TBIO's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for TBIO's Competitors
Inventory Turnover Ratio for TBIO's Suppliers
Inventory Turnover Ratio for TBIO's Customers

You may also want to know
TBIO's Sales Growth Rates	TBIO's Pe Price to earnings ratio	TBIO's Receivables Turnover Ratio	TBIO's Stock Quote
TBIO's Net Income Growth Rates	TBIO's Ps Price to Sales ratio	TBIO's Sales per Employee	TBIO's Asset Turnover Ratio
TBIO's Net Margin	TBIO's Pb Price to Book ratio	TBIO's Financial Strength Ratios	TBIO's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Sep 30 2024	Inventories at quarter ending Sep 30 2024
Pavmed Inc	18.54	$ 6.401 Millions	$ 0 Millions
Labcorp Holdings Inc	18.24	$ 8,547.800 Millions	$ 469 Millions
Bespoke Extracts Inc	18.07	$ 0.593 Millions	$ 0 Millions
Semler Scientific inc	17.41	$ 7.043 Millions	$ 0 Millions
Novavax inc	17.06	$ 321.046 Millions	$ 19 Millions
The Oncology Institute Inc	16.25	$ 189.501 Millions	$ 12 Millions
Aspira Women s Health inc	15.35	$ 3.757 Millions	$ 0 Millions
Opko Health Inc	15.31	$ 936.221 Millions	$ 61 Millions
Natera Inc	14.92	$ 647.172 Millions	$ 43 Millions
Universe Pharmaceuticals Inc	14.85	$ 16,952.556 Millions	$ 1,142 Millions
Invo Fertility Inc	14.18	$ 3.626 Millions	$ 0 Millions
Neuraxis Inc	13.76	$ 0.367 Millions	$ 0 Millions
Rockwell Medical inc	13.70	$ 81.223 Millions	$ 6 Millions
Option Care Health Inc	13.66	$ 3,782.914 Millions	$ 277 Millions
Electromedical Technologies Inc	12.74	$ 0.545 Millions	$ 0 Millions
Irhythm Holdings Inc	12.09	$ 179.245 Millions	$ 15 Millions
Puma Biotechnology Inc	11.55	$ 74.806 Millions	$ 6 Millions
Sunlink Health Systems Inc	11.49	$ 17.957 Millions	$ 2 Millions
Cryo cell International Inc	11.32	$ 8.387 Millions	$ 1 Millions
Genedx Holdings Corp	10.42	$ 108.097 Millions	$ 10 Millions
Myriad Genetics Inc	10.28	$ 254.100 Millions	$ 25 Millions
Jin Medical International Ltd	10.16	$ 13.892 Millions	$ 1 Millions
Infusystem Holdings Inc	10.04	$ 65.716 Millions	$ 7 Millions
Blue Water Vaccines Inc	9.99	$ 2.603 Millions	$ 0 Millions
Sotera Health Company	9.51	$ 501.913 Millions	$ 53 Millions
Agape Atp Corporation	9.50	$ 0.519 Millions	$ 0 Millions
Bgm Group Ltd	8.68	$ 20.983 Millions	$ 2 Millions
Star Equity Holdings Inc	8.41	$ 40.914 Millions	$ 5 Millions
Mangoceuticals Inc	8.33	$ 0.125 Millions	$ 0 Millions
Vanda Pharmaceuticals Inc	8.20	$ 12.184 Millions	$ 1 Millions

Date modified: 2026-09-08T15:22:13+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.